CardioSignal, a Finland-based health tech company specializing in the development of a unique, non-invasive atrial fibrillation detection technology, raised $10M in Series A funding. The funds will be used to accelerate the company's international growth and further develop it...
CardioSignal non
Feb 4, 2024
—